<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2007-13-2-141-144</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1119</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Сравнительная эффективность
фиксированных комбинаций верапамил
СР + трандолаприл и каптоприл+
гидрохлортиазид у больных артериальной
гипертензией высокого риска</article-title><trans-title-group xml:lang="en"><trans-title>Comparison of efficacy of fixed
combinations of verapamil SR+ trandolapril
and captopril + HCTZ in high risk
hypertensive patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Недогода</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nedogoda</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чаляби</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chalabi</surname><given-names>Т. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цома</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsoma</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брель</surname><given-names>У. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Brel</surname><given-names>U. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Кафедра терапии и семейной медицины ФУВа, Волгоградский государственный медицинский университет</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>28</day><month>04</month><year>2007</year></pub-date><volume>13</volume><issue>2</issue><fpage>141</fpage><lpage>144</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Недогода С.В., Чаляби Т.А., Цома В.В., Брель У.А., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Недогода С.В., Чаляби Т.А., Цома В.В., Брель У.А.</copyright-holder><copyright-holder xml:lang="en">Nedogoda S.V., Chalabi Т.A., Tsoma V.V., Brel U.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1119">https://htn.almazovcentre.ru/jour/article/view/1119</self-uri><abstract><p>Проведено сравнение клинической эффективности и переносимости фиксированных комбинаций Тарка и Капозид у больных АГ I-II ст. тяжести высокого и очень высокого риска, ненормализовавших АД на предшествующей монотерапии. Исследование было ослепленным, рандомизированным («метод конвертов») с параллельными группами (по 20 человек в каждой). Больные получали в течение 6 месяцев по 1 таблетке препарата Тарка или Капозид. По своей антигипертензивной активности и способности уменьшать ГЛЖ и улучшать эластичность артерий Тарка существенно превосходит Капозид. Аналогичная зависимость выявлена и в отношении показателя Т/Р*. Тарка благоприятно влияет на уровень глюкозы крови, а Капозид оказывает негативное влияние на уровень калия.</p></abstract><trans-abstract xml:lang="en"><p>The blinded randomized study the clinical effecacy and tolerability during 6 month therapy with one of two fixed combinations Tarka (verapamil SR+trandolapril) and Capozide (captopril+HCTZ) were compared patients (20 patients at every group) with arterial hypertension who did not achiev target blood pressure on monotherapy. Tarka was more effective decreased of left ventricular hypertrophy and improved vascular elasticity. Tarka also had better T/P coefficient. Tarka improved glucose level, Capozide worsen potassium levels.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>Тарка</kwd><kwd>Капозид</kwd><kwd>комбинированная терапия</kwd><kwd>сосудистая эластичность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>Tarka (verapamil SR+trandolapril) and Capozide (captopril+HCTZ)</kwd><kwd>fixed combinations</kwd><kwd>vascular elasticity</kwd><kwd>pulse wave velocity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Артер. гипертен. 2001; 7 (1): (Приложение).</mixed-citation><mixed-citation xml:lang="en">Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Артер. гипертен. 2001; 7 (1): (Приложение).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Commitee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VII). JAMA May 21, 2003; 289 (19):</mixed-citation><mixed-citation xml:lang="en">Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Commitee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VII). JAMA May 21, 2003; 289 (19):</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">European Society of Cardiology. Guidelines for the management of arterial Hypertension. Guidelines Committee. J of Hypertension 2003; 21: 1011-53.</mixed-citation><mixed-citation xml:lang="en">European Society of Cardiology. Guidelines for the management of arterial Hypertension. Guidelines Committee. J of Hypertension 2003; 21: 1011-53.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zillich A.J., Garg J., Basu S., Bakris G.L., et al. Thiazide Diuretics, Potassium, and the Development of Diabetes. A Quantitative Review. Hypertension. 2006;. 48(2):219-224.</mixed-citation><mixed-citation xml:lang="en">Zillich A.J., Garg J., Basu S., Bakris G.L., et al. Thiazide Diuretics, Potassium, and the Development of Diabetes. A Quantitative Review. Hypertension. 2006;. 48(2):219-224.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Luccioni R., Sever P.S., Di Perri T. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.J Hypertens. 1995 13(12 Pt 2):1847-51.</mixed-citation><mixed-citation xml:lang="en">Luccioni R., Sever P.S., Di Perri T. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.J Hypertens. 1995 13(12 Pt 2):1847-51.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dablof B., Sever P.S., Poulter N.R., for the ASCOT investigators. 2005; 366: 895-906.</mixed-citation><mixed-citation xml:lang="en">Dablof B., Sever P.S., Poulter N.R., for the ASCOT investigators. 2005; 366: 895-906.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
